Tissue Velocity Echocardiography Shows Early Improvement in Diastolic Function With Irbesartan and Atenolol Therapy in Patients With Hypertensive Left Ventricular Hypertrophy. Results From the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA)

American Journal of Hypertension

Volumn 19, Issue 9, 2006, Pages 927-936

  Müller Brunotte, Richard ^a   Kahan, Thomas ^a   Malmqvist, Karin ^a   Ring, Margareta ^a   Edner, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

diastolic function; echocardiography; heart; Hypertension; left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; IRBESARTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAXATION TIME; RISK ASSESSMENT; SENSITIVITY ANALYSIS; VELOCITY;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BIPHENYL COMPOUNDS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CONFOUNDING FACTORS (EPIDEMIOLOGY); DIASTOLE; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; STROKE VOLUME; SWEDEN; TETRAZOLES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 33845362310     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2006.02.009     Document Type: Article

References (28)

1. Casale P.N., Devereux R.B., Milner M., Zullo G., Harshfield G.A., Pickering T.G., and Laragh J.H. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 105 (1986) 173-178
2. Verdecchia P., Angeli F., Borgioni C., Gattobigio R., de Simone G., Devereux R.B., and Porcellati C. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension. a meta-analysis. Am J Hypertens 16 (2003) 895-899
3. Levy D., Larson M.G., Vasan R.S., Kannel W.B., and Ho K.K. The progression from hypertension to congestive heart failure. JAMA 275 (1996) 1557-1562
4. Aurigemma G.P., Gottdiener J.S., Shemanski L., Gardin J., and Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly. the cardiovascular health study. J Am Coll Cardiol 37 (2001) 1042-1048
5. Redfield M.M., Jacobsen S.J., Burnett Jr. J.C., Mahoney D.W., Bailey K.R., and Rodeheffer R.J. Burden of systolic and diastolic ventricular dysfunction in the community. appreciating the scope of the heart failure epidemic. JAMA 289 (2003) 194-202
6. Nishimura R.A., Housmans P.R., Hatle L.K., and Tajik A.J. Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part I. Physiologic and pathophysiologic features. Mayo Clin Proc 64 (1989) 71-81
7. Garcia M.J., Rodriguez L., Ares M., Griffin B.P., Klein A.L., Stewart W.J., and Thomas J.D. Myocardial wall velocity assessment by pulsed Doppler tissue imaging. characteristic findings in normal subjects. Am Heart J 132 (1996) 648-656
8. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., and Quinones M.A. Doppler tissue imaging. a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30 (1997) 1527-1533
9. Naqvi T.Z., Neyman G., Broyde A., Mustafa J., and Siegel R.J. Comparison of myocardial tissue Doppler with transmitral flow Doppler in left ventricular hypertrophy. J Am Soc Echocardiogr 14 (2001) 1153-1160
10. Weber K.T., and Brilla C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83 (1991) 1849-1865
11. Malmqvist K., Kahan T., Edner M., Held C., Hägg A., Lind L., Müller-Brunotte R., Nyström F., Öhman K.P., Osbakken M.D., and Östergern J. Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens 19 (2001) 1167-1176
12. Devereux R.B., Alonso D.R., Lutas E.M., Gottlieb G.J., Campo E., Sachs I., and Reichek N. Echocardiographic assessment of left ventricular hypertrophy. comparison to necropsy findings. Am J Cardiol 57 (1986) 450-458
13. Levy D., Anderson K.M., Savage D.D., Kannel W.B., Christiansen J.C., and Castelli W.P. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study. Ann Intern Med 108 (1988) 7-13
14. Müller-Brunotte R., Edner M., Malmqvist K., and Kahan T. Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy. J Hypertens 23 (2005) 633-640
15. Müller-Brunotte R., Kahan T., Malmqvist K., and Edner M. Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy. J Hum Hypertens 17 (2003) 841-849
16. Edner M., Jarnert C., Müller-Brunotte R., Malmqvist K., Ring M., Kjerr A.C., Lind L., and Kahan T. Influence of age and cardiovascular factors on regional pulsed wave Doppler myocardial imaging indices. Eur J Echocardiogr 1 (2000) 87-95
17. Ommen S.R., Nishimura R.A., Appleton C.P., Miller F.A., Oh J.K., Redfield M.M., and Tajik A.J. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures. a comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
18. Di Bello V., Giorgi D., Pedrinelli R., Talini E., Palagi C., Delle Donne M.G., Zucchelli G., Dell'omo G., Di Cori A., Dell'Anna R., Caravelli P., and Mariani M. Left ventricular hypertrophy and its regression in essential arterial hypertension. A tissue Doppler imaging study. Am J Hypertens 17 (2004) 882-890
19. Onose Y., Oki T., Yamada H., Manabe K., Kageji Y., Matsuoka M., Yamamoto T., Tabata T., Wakatsuki T., and Ito S. Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging. Jpn Circ J 65 (2001) 305-309
20. Tanaka H., Oki T., Tabata T., Yamada H., Harada K., Kimura E., Oishi Y., Ishimoto T., and Ito S. Losartan improves regional left ventricular systolic and diastolic function in patients with hypertension. accurate evaluation using a newly developed color-coded tissue Doppler imaging technique. J Card Fail 10 (2004) 412-420
21. Oki T., Tabata T., Yamada H., Wakatsuki T., Shinohara H., Nishikado A., Iuchi A., Fukuda N., and Ito S. Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 79 (1997) 921-928
22. Ohno M., Cheng C.P., and Little W.C. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 89 (1994) 2241-2250
23. Galderisi M., Caso P., Severino S., Petrocelli A., de Simone L., Izzo A., Mininni N., and de Divitiis O. Myocardial diastolic impairment caused by left ventricular hypertrophy involves basal septum more than other walls. analysis by pulsed Doppler tissue imaging. J Hypertens 17 (1999) 685-693
24. Peverill R.E., Gelman J.S., Mottram P.M., Moir S., Jankelowitz C., Bain J.L., and Donelan L. Factors associated with mitral annular systolic and diastolic velocities in healthy adults. J Am Soc Echocardiogr 17 (2004) 1146-1154
25. Devereux R.B., Dahlöf B., Levy D., and Pfeffer M.A. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol 78 (1996) 61-65
26. Rodriguez L., Garcia M., Ares M., Griffin B.P., Nakatani S., and Thomas J.D. Assessment of mitral annular dynamics during diastole by Doppler tissue imaging. comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy. Am Heart J 131 (1996) 982-987
27. Malmqvist K., Öhman K.P., Lind L., Nyström F., and Kahan T. Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension. the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). J Cardiovasc Pharmacol 42 (2003) 719-726
28. Yusuf S., Pfeffer M.A., Swedberg K., Granger C.B., Held P., McMurray J.J., Michelson E.L., Olofsson B., and Östergren J. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction. the CHARM-Preserved Trial. Lancet 362 (2003) 777-781